Insights & Innovators

RWE Industry Insights

Innovating RWE Organizations: Learning from the Past and Looking to the Future

A Q&A with Christopher Boone, PhD, FACHE, FHIMMS Christopher Boone, PhD, is Vice President, Global Head of Health Economics and Outcomes Research at AbbVie. He is also an adjunct assistant professor of health administration at the New York University's Robert F. Wagner Graduate School of Public Service, an active board member of several health[…]

Q&A

How are Data Networks and International Collaboration Furthering Epidemiologic Research? A Q&A with Samy Suissa, PhD

Dr. Samy Suissa is a Co-Founder and Principal Investigator of the Canadian Network for Observational Drug Effect Studies (CNODES). He is Director of the Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research at the Jewish General Hospital and Professor, Departments of Epidemiology and Biostatistics and of Medicine, McGill[…]

ICER

You Can Influence ICER Recommendations, You Just Need the Right Evidence

It’s difficult to dispute the findings of an advisory group which is widely accepted as the authority, especially when it comes to evaluating the value of different therapeutic interventions. The cost of drugs in the U.S. has been a hot button topic in recent years, so healthcare industry stakeholders are increasingly looking for objective[…]

Panalgo News

BHE is Now Panalgo: Why We Changed Our Name and Brand

In 1996, I started Boston Health Economics (BHE) to provide professional research services to the life sciences industry, including economic modeling, database analyses and strategic consulting. For more than two decades we have had the privilege of serving the industry’s leading life sciences organizations.

Instant Health Data

Put reliable, rapid analytics in the hands of more people across your organization

Learn more about Panalgo

Get the story behind our work and our team.